Zimmer Biomet Holdings, Inc. (SWX:ZBH)

Market Cap	15.04B
Revenue (ttm)	6.81B
Net Income (ttm)	807.40M
Shares Out	n/a
EPS (ttm)	3.98
PE Ratio	18.63
Forward PE	11.44
Dividend	0.84 (0.77%)
Ex-Dividend Date	Mar 31, 2025

Volume	n/a
Average Volume	41
Open	n/a
Previous Close	109.00
Day's Range	n/a
52-Week Range	97.00 - 113.00
Beta	1.01
RSI	84.32
Earnings Date	Aug 4, 2025

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open hear...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1927
• Employees: 17,000
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: ZBH

Financial Performance

In 2024, Zimmer Biomet Holdings's revenue was $7.68 billion, an increase of 3.85% compared to the previous year's $7.39 billion. Earnings were $903.80 million, a decrease of -11.74%.

Financial numbers in USD